486 related articles for article (PubMed ID: 19006648)
1. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.
Li N; Fu H; Tie Y; Hu Z; Kong W; Wu Y; Zheng X
Cancer Lett; 2009 Mar; 275(1):44-53. PubMed ID: 19006648
[TBL] [Abstract][Full Text] [Related]
2. miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway.
Tan S; Li R; Ding K; Lobie PE; Zhu T
FEBS Lett; 2011 Jul; 585(14):2229-34. PubMed ID: 21658389
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S
FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026
[TBL] [Abstract][Full Text] [Related]
5. The impact of miR-34a on protein output in hepatocellular carcinoma HepG2 cells.
Cheng J; Zhou L; Xie QF; Xie HY; Wei XY; Gao F; Xing CY; Xu X; Li LJ; Zheng SS
Proteomics; 2010 Apr; 10(8):1557-72. PubMed ID: 20186752
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of c-Met expression inhibits human HCC cells growth and invasion by RNA interference.
Xie B; Xing R; Chen P; Gou Y; Li S; Xiao J; Dong J
J Surg Res; 2010 Aug; 162(2):231-8. PubMed ID: 19765730
[TBL] [Abstract][Full Text] [Related]
7. Involvement of protein kinase C beta-extracellular signal-regulating kinase 1/2/p38 mitogen-activated protein kinase-heat shock protein 27 activation in hepatocellular carcinoma cell motility and invasion.
Guo K; Liu Y; Zhou H; Dai Z; Zhang J; Sun R; Chen J; Sun Q; Lu W; Kang X; Chen P
Cancer Sci; 2008 Mar; 99(3):486-96. PubMed ID: 18167130
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-34a inhibits cell proliferation by repressing mitogen-activated protein kinase kinase 1 during megakaryocytic differentiation of K562 cells.
Ichimura A; Ruike Y; Terasawa K; Shimizu K; Tsujimoto G
Mol Pharmacol; 2010 Jun; 77(6):1016-24. PubMed ID: 20299489
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1.
Wu J; Wu G; Lv L; Ren YF; Zhang XJ; Xue YF; Li G; Lu X; Sun Z; Tang KF
Carcinogenesis; 2012 Mar; 33(3):519-28. PubMed ID: 22198213
[TBL] [Abstract][Full Text] [Related]
10. miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma.
Zhu Q; Wang Z; Hu Y; Li J; Li X; Zhou L; Huang Y
Oncol Rep; 2012 May; 27(5):1660-8. PubMed ID: 22322403
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
Luan S; Sun L; Huang F
Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
[TBL] [Abstract][Full Text] [Related]
12. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells.
Fornari F; Milazzo M; Chieco P; Negrini M; Calin GA; Grazi GL; Pollutri D; Croce CM; Bolondi L; Gramantieri L
Cancer Res; 2010 Jun; 70(12):5184-93. PubMed ID: 20501828
[TBL] [Abstract][Full Text] [Related]
13. In vitro c-met inhibition by antisense RNA and plasmid-based RNAi down-modulates migration and invasion of hepatocellular carcinoma cells.
Salvi A; Arici B; Portolani N; Giulini SM; De Petro G; Barlati S
Int J Oncol; 2007 Aug; 31(2):451-60. PubMed ID: 17611703
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of SMYD3 by RNA interference down-regulates c-Met expression and inhibits cells migration and invasion induced by HGF.
Zou JN; Wang SZ; Yang JS; Luo XG; Xie JH; Xi T
Cancer Lett; 2009 Jul; 280(1):78-85. PubMed ID: 19321255
[TBL] [Abstract][Full Text] [Related]
15. miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.
Gandellini P; Folini M; Longoni N; Pennati M; Binda M; Colecchia M; Salvioni R; Supino R; Moretti R; Limonta P; Valdagni R; Daidone MG; Zaffaroni N
Cancer Res; 2009 Mar; 69(6):2287-95. PubMed ID: 19244118
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer.
Asangani IA; Rasheed SA; Nikolova DA; Leupold JH; Colburn NH; Post S; Allgayer H
Oncogene; 2008 Apr; 27(15):2128-36. PubMed ID: 17968323
[TBL] [Abstract][Full Text] [Related]
17. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.
Fornari F; Gramantieri L; Giovannini C; Veronese A; Ferracin M; Sabbioni S; Calin GA; Grazi GL; Croce CM; Tavolari S; Chieco P; Negrini M; Bolondi L
Cancer Res; 2009 Jul; 69(14):5761-7. PubMed ID: 19584283
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-34a targets Bcl-2 and sensitizes human hepatocellular carcinoma cells to sorafenib treatment.
Yang F; Li QJ; Gong ZB; Zhou L; You N; Wang S; Li XL; Li JJ; An JZ; Wang DS; He Y; Dou KF
Technol Cancer Res Treat; 2014 Feb; 13(1):77-86. PubMed ID: 23862748
[TBL] [Abstract][Full Text] [Related]
19. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer.
Gallardo E; Navarro A; Viñolas N; Marrades RM; Diaz T; Gel B; Quera A; Bandres E; Garcia-Foncillas J; Ramirez J; Monzo M
Carcinogenesis; 2009 Nov; 30(11):1903-9. PubMed ID: 19736307
[TBL] [Abstract][Full Text] [Related]
20. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.
Fornari F; Gramantieri L; Ferracin M; Veronese A; Sabbioni S; Calin GA; Grazi GL; Giovannini C; Croce CM; Bolondi L; Negrini M
Oncogene; 2008 Sep; 27(43):5651-61. PubMed ID: 18521080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
